Roquefort Therapeutics plc
ROQ.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £183 | £337 | £596 | £537 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £31 | £25 | £87 | £158 |
| Inventory | £0 | £0 | £0 | -£158 |
| Other Curr. Assets | £1,544 | £0 | £0 | £105 |
| Total Curr. Assets | £1,758 | £362 | £683 | £695 |
| Property Plant & Equip (Net) | £42 | £45 | £47 | £50 |
| Goodwill | £0 | £282 | £0 | £282 |
| Intangibles | £3,862 | £5,062 | £5,344 | £5,062 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £0 | £0 | £0 |
| Total NC Assets | £3,904 | £5,388 | £5,391 | £5,394 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £5,662 | £5,751 | £6,074 | £6,089 |
| Liabilities | – | – | – | – |
| Payables | £134 | £23 | £136 | £145 |
| Short-Term Debt | £384 | £400 | £610 | £0 |
| Tax Payable | £0 | £0 | £0 | £0 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £110 | £157 | £0 | £162 |
| Total Curr. Liab. | £627 | £580 | £863 | £307 |
| LT Debt | £0 | £0 | £0 | £0 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £282 | £282 | £282 | £282 |
| Other NC Liab. | £0 | £0 | £0 | £0 |
| Total NC Liab. | £282 | £282 | £282 | £282 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £0 | £0 | £0 | £0 |
| Total Liabilities | £909 | £862 | £1,145 | £589 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £1,574 | £1,357 | £1,292 | £1,292 |
| Retained Earnings | -£5,755 | -£5,265 | -£1,173 | -£593 |
| AOCI | £4,200 | £4,177 | £4,107 | £398 |
| Other Equity | £0 | £0 | -£3,700 | £0 |
| Total Equity | £4,753 | £4,889 | £4,929 | £5,500 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £5,662 | £5,751 | £6,074 | £6,089 |
| Net Debt | £201 | £63 | £14 | -£537 |